Christopher C Nolan

Christopher C Nolan

UNVERIFIED PROFILE

Are you Christopher C Nolan?   Register this Author

Register author
Christopher C Nolan

Christopher C Nolan

Publications by authors named "Christopher C Nolan"

Are you Christopher C Nolan?   Register this Author

40Publications

552Reads

8Profile Views

The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer.

Breast Cancer Res Treat 2019 May 22;175(1):27-38. Epub 2019 Jan 22.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-05111-wDOI Listing
May 2019

Glutamate dehydrogenase (GLUD1) expression in breast cancer.

Breast Cancer Res Treat 2019 Feb 23;174(1):79-91. Epub 2018 Nov 23.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-5060-zDOI Listing
February 2019

Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.

Breast Cancer Res Treat 2019 Jan 10;173(1):93-102. Epub 2018 Oct 10.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-018-4978-5
Publisher Site
http://dx.doi.org/10.1007/s10549-018-4978-5DOI Listing
January 2019

Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance.

Histopathology 2018 Dec 9;73(6):887-896. Epub 2018 Oct 9.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13695DOI Listing
December 2018

Thioredoxin-interacting protein is an independent risk stratifier for breast ductal carcinoma in situ.

Mod Pathol 2018 12 28;31(12):1807-1815. Epub 2018 Jun 28.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0086-7DOI Listing
December 2018

Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion.

Mod Pathol 2018 11 28;31(11):1675-1682. Epub 2018 Jun 28.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0092-9DOI Listing
November 2018

The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes.

Br J Cancer 2018 04 16;118(8):1115-1122. Epub 2018 Mar 16.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0038-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931111PMC
April 2018

Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.

Br J Cancer 2018 04 28;118(8):1142-1151. Epub 2018 Mar 28.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0041-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931067PMC
April 2018

The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours.

Breast Cancer Res 2018 03 22;20(1):21. Epub 2018 Mar 22.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-018-0946-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863851PMC
March 2018

MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer.

Br J Cancer 2018 01 23;118(2):258-265. Epub 2017 Nov 23.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/bjc.2017.387
Publisher Site
http://dx.doi.org/10.1038/bjc.2017.387DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785743PMC
January 2018

Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.

Histopathology 2017 Aug 26;71(2):258-268. Epub 2017 May 26.

Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13217DOI Listing
August 2017

Phenotypic characterisation of breast cancer: the role of CDC42.

Breast Cancer Res Treat 2017 Jul 27;164(2):317-325. Epub 2017 Apr 27.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4267-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487723PMC
July 2017

Further evidence to support bimodality of oestrogen receptor expression in breast cancer.

Histopathology 2017 Feb 28;70(3):456-465. Epub 2016 Nov 28.

Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13089DOI Listing
February 2017

The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts.

Breast Cancer Res Treat 2016 Feb 23;156(1):9-20. Epub 2016 Feb 23.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3709-zDOI Listing
February 2016

Clinical utility of reverse phase protein array for molecular classification of breast cancer.

Breast Cancer Res Treat 2016 Jan 9;155(1):25-35. Epub 2015 Dec 9.

Department of Histopathology, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2Fs10549-015-36
Web Search
http://link.springer.com/10.1007/s10549-015-3654-2
Publisher Site
http://dx.doi.org/10.1007/s10549-015-3654-2DOI Listing
January 2016

Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series.

J Pathol Clin Res 2016 Jan 15;2(1):32-40. Epub 2016 Jan 15.

Division of Cancer and Stem CellsBreast Cancer Pathology Research Group, School of Medicine, University of Nottingham, Nottingham City HospitalHucknall RoadNottinghamNG5 1PB; Cellular Pathology, Nottingham University Hospitals NHS TrustHucknall RoadNottinghamNG5 1PB.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cjp2.32DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858129PMC
January 2016

DNA damage response markers are differentially expressed in BRCA-mutated breast cancers.

Breast Cancer Res Treat 2015 Feb 19;150(1):81-90. Epub 2015 Feb 19.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-015-3306-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344553PMC
February 2015

Biological and clinical significance of PARP1 protein expression in breast cancer.

Breast Cancer Res Treat 2015 Jan 21;149(2):353-62. Epub 2014 Dec 21.

Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-3230-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308637PMC
January 2015

Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study.

Breast Cancer Res Treat 2014 Jun 26;145(2):339-48. Epub 2014 Apr 26.

Department of Histopathology, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2927-5DOI Listing
June 2014

HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancer.

Breast Cancer Res Treat 2014 May 6;145(1):33-44. Epub 2014 Apr 6.

Molecular Pathology Research Unit, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, NG5 1PB, UK,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-014-2925-7
Publisher Site
http://dx.doi.org/10.1007/s10549-014-2925-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984415PMC
May 2014

Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay.

Breast Cancer Res Treat 2014 Apr 21;144(2):273-85. Epub 2014 Feb 21.

Molecular Pathology Research Unit, Division of Oncology, School of Medicine, Nottingham City Hospital, University of Nottingham, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2871-4DOI Listing
April 2014

SHON is a novel estrogen-regulated oncogene in mammary carcinoma that predicts patient response to endocrine therapy.

Cancer Res 2013 Dec;73(23):6951-62

Authors' Affiliations: Liggins Institute, University of Auckland, Auckland, New Zealand; Department of Clinical Oncology; Department of Histopathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; The Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University; The Institute of Genetics and Cytology, Northeast Normal University, Changchun; Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing; Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China; Department of Pathology, Anhui Medical University, Hefei, China; Cancer Science Institute of Singapore, and Department of Pharmacology, National University of Singapore; and National Cancer Institute of Singapore, National University Health System, Singapore.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/73/23/6951.full.pd
Web Search
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-13-0982DOI Listing
December 2013

Poly(adenosine diphosphate-ribose) polymerase expression in BRCA-proficient ovarian high-grade serous carcinoma; association with patient survival.

Hum Pathol 2013 Aug 8;44(8):1638-47. Epub 2013 Apr 8.

Department of Histopathology, Nottingham University Hospitals NHS Trust, Queen's Medical Centre Campus, Nottingham, NG7 2UH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2013.01.015DOI Listing
August 2013

A quantifier-based fuzzy classification system for breast cancer patients.

Artif Intell Med 2013 Jul 18;58(3):175-84. Epub 2013 Jun 18.

School of Computer Science, Advanced Data Analysis Centre, University of Nottingham, Jubilee Campus, Wollaton Road, Nottingham NG8 1BB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.artmed.2013.04.006DOI Listing
July 2013

The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients.

Breast Cancer Res Treat 2013 Jan 6;137(1):139-53. Epub 2012 Dec 6.

Department of Histopathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2358-0DOI Listing
January 2013

TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome.

Breast Cancer Res Treat 2012 Nov 4;136(2):419-27. Epub 2012 Oct 4.

Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2249-4DOI Listing
November 2012

Loss of Dicer expression is associated with breast cancer progression and recurrence.

Breast Cancer Res Treat 2012 Sep 21;135(2):403-13. Epub 2012 Jul 21.

Department of Histopathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2169-3DOI Listing
September 2012

Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer.

Breast Cancer Res Treat 2012 Jul 6;134(2):519-29. Epub 2012 May 6.

Department of Histopathology and School of Molecular Medical Sciences, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-012-2083-8
Publisher Site
http://dx.doi.org/10.1007/s10549-012-2083-8DOI Listing
July 2012

Pathological outcomes in kidney and brain in male Fischer rats given dietary ochratoxin A, commencing at one year of age.

Toxins (Basel) 2010 05 13;2(5):1100-10. Epub 2010 May 13.

Centre for Environmental Policy, Imperial College London, London, SW7 2AZ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/toxins2051100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153236PMC
May 2010

Reversible disruption of tight junction complexes in the rat blood-brain barrier, following transitory focal astrocyte loss.

Glia 2004 Oct;48(1):1-13

MRC Applied Neuroscience Group, School of Biomedical Sciences, Queen's Medical Centre, University of Nottingham, NG7 2UH, Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/glia.20049DOI Listing
October 2004

Focal astrocyte loss is followed by microvascular damage, with subsequent repair of the blood-brain barrier in the apparent absence of direct astrocytic contact.

Glia 2004 Mar;45(4):325-37

MRC Applied Neuroscience Group, School of Biomedical Sciences, Queens Medical Centre, University of Nottingham, Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/glia.10333DOI Listing
March 2004

Microglial activation and increased synthesis of complement component C1q precedes blood-brain barrier dysfunction in rats.

Mol Immunol 2004 Jan;40(10):709-16

Department of Infection, Immunity and Inflammation, University of Leicester, University Road, Leicester LE1 9HN, UK.

View Article

Download full-text PDF

Source
January 2004